Lactobacillus Sigma Factor Engineering for Acid Tolerance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for improving industrial bioconversions, such as mutagenesis and gene shuffling, often result in untransferable and intractable genomic changes, making it difficult to achieve robust biocatalysts with enhanced tolerance to stresses like high temperature, acidity, and osmotic pressure, especially when the underlying genetic modifications are unclear.
Innovation Solution
Global transcription machinery engineering (gTME) is employed to introduce mutated sigma factors in bacteria like Lactobacillus plantarum, allowing for improved tolerance to lactic acid and low pH conditions by altering the genome-wide promoter preferences, thereby enhancing phenotypic responses and metabolite production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional mutagenesis and gene shuffling are used to improve industrial bioconversions, then phenotypic diversity can be generated, but the genomic changes become untransferable and intractable
Solution Approach 1:
The patent extracts the essential transcriptional regulation function from the complex genomic background by focusing specifically on sigma factor manipulation. This allows the phenotypic improvements to be decoupled from the messy genomic changes, making them transferable. The sigma factor acts as a portable regulatory element that can be moved between strains without carrying the associated genomic complexity.
Solution Approach 2:
The sigma factor serves multiple functions: it regulates transcription initiation, determines promoter specificity, and controls gene expression patterns across the genome. By manipulating this single universal regulatory element, the patent achieves broad phenotypic changes that are transferable across different bacterial strains, unlike strain-specific genomic modifications.
2Reliability
If random mutagenesis is performed to achieve robust biocatalysts, then tolerance to stresses can be improved, but the underlying genetic modifications become unclear and intractable
Solution Approach 1:
Instead of random genome-wide mutagenesis, the patent applies targeted mutagenesis to the sigma factor gene. This local approach maintains clarity about the genetic modification while achieving stress tolerance. The focused mutation in the sigma factor provides predictable, understandable changes that lead to improved stress tolerance without the complexity of random genomic changes.
Solution Approach 2:
The sigma factor acts as an intermediary between the genetic modification and the stress tolerance phenotype. By modifying this intermediate regulatory element, the patent creates a clear causal chain: sigma factor mutation → altered transcriptional profile → improved stress tolerance. This intermediary approach maintains information clarity while achieving the desired reliability.
3Adaptability or versatility
If global transcription machinery engineering is used to improve phenotypes, then transferable multilocus responses can be achieved, but the complexity of transcriptional regulation increases
Solution Approach 1:
The sigma factor serves as a universal regulatory element that controls multiple loci simultaneously. By modifying this single element, the patent achieves coordinated changes across many genes without the complexity of manipulating each locus individually. This universal approach enables transferable multilocus responses while keeping the intervention simple.
Solution Approach 2:
The patent changes key parameters of the sigma factor (amino acid substitutions, promoter binding affinity) to alter its regulatory function. These parameter changes in a single protein lead to cascading effects across the transcriptome, achieving complex multilocus responses through simple, transferable modifications to one regulatory element.
4Reliability
If serial rounds of mutagenesis are performed to obtain robust biocatalysts, then stress tolerance can be improved, but the time and resources required increase significantly
Solution Approach 1:
The patent performs preliminary action by directly modifying the sigma factor to establish improved stress tolerance in a single step, rather than through serial mutagenesis rounds. This upfront modification of the key regulatory element creates a foundation for robustness that eliminates the need for multiple iterative improvement cycles, significantly reducing development time.
Solution Approach 2:
By changing critical parameters of the sigma factor (such as promoter binding regions and amino acid composition), the patent achieves rapid phenotypic improvement in one generation. This direct parameter modification approach replaces time-consuming serial mutagenesis while maintaining or improving stress tolerance, dramatically accelerating strain development.
Data Source
AI summary
The invention relates to global transcription machinery engineering to produce altered cells having improved phenotypes and methods for evaluating phenotypic diversity.